Ikarian Capital, LLC Exact Sciences Corp Transaction History
Ikarian Capital, LLC
- $573 Million
- Q3 2024
A detailed history of Ikarian Capital, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Ikarian Capital, LLC holds 205,000 shares of EXAS stock, worth $10.1 Million. This represents 0.91% of its overall portfolio holdings.
Number of Shares
205,000Holding current value
$10.1 Million% of portfolio
0.91%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding EXAS
# of Institutions
671Shares Held
163MCall Options Held
2.58MPut Options Held
2.19M-
Vanguard Group Inc Valley Forge, PA17.8MShares$876 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA15.8MShares$781 Million0.17% of portfolio
-
Wellington Management Group LLP Boston, MA14.3MShares$707 Million0.18% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$595 Million0.01% of portfolio
-
State Street Corp Boston, MA6.68MShares$330 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $8.73B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...